Cevazuril 50 mg/ml, oral suspension for piglets and calves アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

cevazuril 50 mg/ml, oral suspension for piglets and calves

ceva santé animale - toltrazuril - oral suspension - 50 milligram(s)/millilitre - toltrazuril - cattle, pigs - coccidiostats

BAYCOX BOVIS 50 MG/ML ORAL SUSPENSION アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

baycox bovis 50 mg/ml oral suspension

bayer limited - toltrazuril - oral suspension - 50 mg/ml - toltrazuril - bovine - coccidiostats

BAYCOX SHEEP, 50 MG/ML ORAL SUSPENSION アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

baycox sheep, 50 mg/ml oral suspension

bayer limited - toltrazuril - oral suspension - 50 mg/ml - toltrazuril - ovine - coccidiostats

TOLTAROX 50 MG/ML ORAL SUSPENSION FOR CATTLE アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

toltarox 50 mg/ml oral suspension for cattle

krka, d.d., novo mesto - toltrazuril - oral suspension - 50 mg/ml - toltrazuril - bovine - coccidiostats

Baycox Bovis 50mg/ml oral suspension アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

baycox bovis 50mg/ml oral suspension

bayer limited - toltrazuril - oral suspension - 50 milligram(s)/millilitre - toltrazuril - cattle - coccidiostats

Baycox Sheep, 50 mg/ml oral suspension. アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

baycox sheep, 50 mg/ml oral suspension.

bayer limited - toltrazuril - oral suspension - 50 milligram(s)/millilitre - toltrazuril - sheep - coccidiostats

Baycox Bovis 50mg/ml oral suspension アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

baycox bovis 50mg/ml oral suspension

elanco gmbh - toltrazuril - oral suspension - 50 milligram(s)/millilitre - toltrazuril

Baycox Sheep, 50 mg/ml oral suspension. アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

baycox sheep, 50 mg/ml oral suspension.

elanco gmbh - toltrazuril - oral suspension - 50 milligram(s)/millilitre - toltrazuril

INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

inqovi 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack

otsuka australia pharmaceutical pty ltd - decitabine, quantity: 35 mg; cedazuridine, quantity: 100 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; hypromellose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - inqovi 35/100 is indicated for the treatment of adult patients with myelodysplastic syndromes (mds) intermediate-1, intermediate-2, and high-risk international prognostic scoring system groups, and patients with chronic myelomonocytic leukaemia (cmml).

INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

inqovi 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle

otsuka australia pharmaceutical pty ltd - decitabine, quantity: 35 mg; cedazuridine, quantity: 100 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; hypromellose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - inqovi 35/100 is indicated for the treatment of adult patients with myelodysplastic syndromes (mds) intermediate-1, intermediate-2, and high-risk international prognostic scoring system groups, and patients with chronic myelomonocytic leukaemia (cmml).